Drug Trial Radar · NCT06938347
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Nov 5, 2025
Primary completion
Nov 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Agitated Solutions, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Apr 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, multicenter, open-label, blinded, crossover trial in which each participant will undergo a randomized sequence of ASI-02 and agitated saline standard of care (SoC) via a saline contrast transthoracic echocardiogram (TTE) study.
Conditions
- Right-To-Left Shunt
Interventions
Agitated Saline SoCDrug
The recommended initial dose of agitated saline SoC is approximately 10 mL of saline containing approximately 1 mL of air, per institutional policy, rapidly mixed (approximately 10-20 presses) to manufacture microbubbles. No additives are allowed to the saline, including blood, dextrose, or bacteriostatic saline.
ASI-02Drug
Each injection shall utilize one (1) ASI-02 product connected to one (1) pre-filled 10 mL 0.9% sodium chloride (saline) syringe. The ASI-02 investigational product will be connected to a standard luer lock connector and administered in its entirety. The intravenous bolus injected dose of ASI-02 is 9 mL of saline and 1 mL of air.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Positive percentage agreement (PPA) of ASI-02 for detecting right-to-left shunt versus agitated saline SoCTime frame: Procedure through 24- to 48-hour participant follow-up visit
- Negative percentage agreement (NPA) of ASI-02 for detecting right-to-left shunt versus agitated saline SoCTime frame: Procedure through 24- to 48-hour participant follow-up visit
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Northwestern University
Chicago, Illinois · Recruiting
AH Illinois Masonic Center
Chicago, Illinois · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
CentraCare
Saint Cloud, Minnesota · Recruiting
Jackson Heart Clinic
Jackson, Mississippi · Recruiting
NYU Langone Health
New York, New York · Recruiting
Aurora St. Lukes Medical Center
Milwaukee, Wisconsin · Recruiting
Toronto General
Toronto, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.